Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study

Bibliographic Details
Main Author: Hayder Al-Momen
Format: Article
Language:English
Published: University of Baghdad/ Al-Kindy College of Medicine 2019-04-01
Series:مجله كليه طب الكندي
Online Access:https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/130
_version_ 1798036850045091840
author Hayder Al-Momen
author_facet Hayder Al-Momen
author_sort Hayder Al-Momen
collection DOAJ
first_indexed 2024-04-11T21:18:38Z
format Article
id doaj.art-69086ca65ea3498190492b3fdad7f2d1
institution Directory Open Access Journal
issn 1810-9543
2521-4365
language English
last_indexed 2024-04-11T21:18:38Z
publishDate 2019-04-01
publisher University of Baghdad/ Al-Kindy College of Medicine
record_format Article
series مجله كليه طب الكندي
spelling doaj.art-69086ca65ea3498190492b3fdad7f2d12022-12-22T04:02:44ZengUniversity of Baghdad/ Al-Kindy College of Medicineمجله كليه طب الكندي1810-95432521-43652019-04-0113110.47723/kcmj.v13i1.130Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension StudyHayder Al-Momenhttps://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/130
spellingShingle Hayder Al-Momen
Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study
مجله كليه طب الكندي
title Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study
title_full Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study
title_fullStr Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study
title_full_unstemmed Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study
title_short Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study
title_sort iron chelation therapy in sickle cell beta thalassemia syndrome a 2 years extension study
url https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/130
work_keys_str_mv AT hayderalmomen ironchelationtherapyinsicklecellbetathalassemiasyndromea2yearsextensionstudy